Portside Wealth Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Buy
6,390
+87
+1% +$8.92K 0.07% 265
2026
Q1
$688K Buy
6,303
+163
+3% +$15.5K 0.09% 211
2025
Q4
$498K Sell
6,140
-206
-3% -$17.7K 0.07% 264
2025
Q3
$555K Buy
6,346
+443
+8% +$39.6K 0.08% 237
2025
Q2
$490K Buy
5,903
+487
+9% +$40.7K 0.07% 251
2025
Q1
$454K Sell
5,416
-678
-11% -$63.1K 0.07% 240
2024
Q4
$562K Buy
6,094
+742
+14% +$71.4K 0.09% 211
2024
Q3
$497K Buy
+5,352
New +$464K 0.08% 227

Other funds holding LMAT

Portside Wealth Group's LMAT Position: Q2 2026 in Review

Portside Wealth Group increased its LeMaitre Vascular (LMAT) stake by 1.4% in Q2 2026, buying an estimated $8.92K and bringing the position to 6,390 shares worth $613K. The position accounts for 0.07% of the portfolio, ranked #265.

Portside Wealth Group first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $688K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Portside Wealth Group held 6,390 shares of LeMaitre Vascular worth $613K as of Q2 2026.
  • Portside Wealth Group bought 87 LeMaitre Vascular shares in Q2 2026, an estimated $8.92K.
  • LeMaitre Vascular made up 0.07% of Portside Wealth Group's portfolio in Q2 2026, its #265 holding.
  • Portside Wealth Group first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • Portside Wealth Group's LeMaitre Vascular position peaked at $688K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.